Nov 6, 2025 11:44 AM Eastern Standard Time Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG Share LEVERKUSEN, Germany--(BUSINESS WIRE)--The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company's Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company's Chief Financial Officer (CFO) on June 1, 2026, following his planned retirement at the end of May 2026. Dr. Hartmann is currently an Operating Partner at Sandbrook Capital, a ...

BREAKING: Futures Mixed Amid Earnings Movers; Elon Musk Pay Vote Due Tesla (TSLA) stock is trading around a buy point with the EV giant's annual shareholder meeting scheduled after the stock market close Thursday. Investors will decide whether to approve CEO Elon Musk's $1 trillion pay deal along with Tesla investment in xAI and several other measures. In the run-up to Thursday's votes. Musk has said the $1 trillion pay proposalâ€| Related news These Are The Best Robinhood Stocks To Buy Or Watch Now 11/05/2 ...

Core Insights - Perplexity will pay Snap $400 million over one year to integrate its AI-powered answer engine into Snapchat [1] - This integration is the first of its kind for Snapchat, aiming to connect AI companies with Snap's 943 million monthly active users [2] Company Strategy - Snap's CEO, Evan Spiegel, emphasized the partnership as a means to enhance discovery and connection on Snapchat, reflecting a shared vision for AI's potential [3] - The integration is part of Snap's strategy to accelerate and diversify revenue growth [3][4] - Snap aims to build out its AI platform and sees a unique opportunity to distribute AI agents through its chat interface [4] User Experience - Perplexity will start appearing in Snapchat in early 2026, allowing users to ask questions and receive conversational answers from verifiable sources [4] - Perplexity will become the default AI for all Snapchat users from January 2026, while users can still interact with the existing My AI chatbot [5]

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Key Takeaways XRAY's Q3 EPS fell 26.5% year over year, missing the consensus estimate by 17.8%.XRAY's revenues declined 4.9% to $904 million, with weakness in most segments except Wellspect Healthcare.XRAY lowered 2025 EPS guidance to about $1.60, while maintaining its sales outlook of $3.6-$3.7 billion.DENTSPLY SIRONA Inc. (XRAY) reported third-quarter 2025 adjusted earnings per share (EPS) of 37 cents, down 26.5% year over year. The bottom line missed the Zacks Consensus Estimate by 17.8%.GAAP loss per sh ...

York Water (YORW) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.16%. A quarter ago, it was expected that this purifying and distribution company would post earnings of $0.33 per share when it actually produced earnings of $0.35, delivering a surprise of +6.06%.Over the last four ...

Core Insights - The AI silicon market is experiencing significant growth, with AMD's CEO Lisa Su indicating that the total addressable market (TAM) for AI silicon has surpassed previous estimates, now viewed as a larger opportunity than the earlier $500 billion projection [1][3]. Group 1: Market Growth and Financial Performance - AMD reported record Q3 revenue of $9.2 billion, driven by strong demand for its MI300 series and the upcoming MI400 roadmap, indicating a robust expansion in the AI compute TAM [2]. - The demand for data center AI chips is surging, suggesting a faster growth trajectory than AMD's initial optimistic forecasts [2]. Group 2: Strategic Partnerships and Future Plans - AMD has established a significant multi-gigawatt, multi-year partnership with OpenAI, with the first gigawatt of deployments expected to begin in the second half of 2026, utilizing the new MI450 series and Helios rack systems [4]. - The company is engaging in discussions with various cloud providers and sovereign AI projects, indicating a strategy to diversify its customer base beyond a single major client [4]. Group 3: Competitive Positioning - While Nvidia currently dominates the AI GPU market, AMD is positioning itself by emphasizing scale and sustainability, aiming to serve multiple hyperscalers simultaneously while addressing power and supply chain challenges [5]. - If the AI silicon market is indeed larger than the $500 billion figure suggested by Su, AMD's growth potential may exceed current Wall Street expectations [5].

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. On October 29, 2025, Avantor, Inc. reported disappointing third quarter 2025 results, including -5% organic revenue growth, which fell short of the guidance the Company had provided in August, and a net loss of $712 million. The Company attributed the loss primarily to ...

The Delaware Chancery Court denied Pfizer Inc.’s (NYSE:PFE) request for a temporary restraining order to prevent Metsera, Inc. (NASDAQ:MTSR)  from terminating the existing merger agreement in favor of a competing proposal from Novo Nordisk A/S (NYSE:NVO).Pfizer responded: “We remain confident in the merits of our claims and our belief that Metsera has acted in breach of its contractual obligations…We are confident that Novo Nordisk’s unprecedented and illegal scheme to circumvent antitrust scrutiny will not ...